WHO issues alert for 4 India-made cough syrups; check symptoms here

WHO has asked not to use these four products until analysed by the relevant national regulatory authorities

On Wednesday, World Health Organization (WHO) issued an alert over four substandard pediatric syrups, which could be the reason behind the deaths of 66 children in The Gambia.

According to WHO, substandard medical products fail to meet their quality standards or specifications and are, therefore, "out of specification". The four mentioned products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. 

All these four products are manufactured in Haryana by Maiden Pharmaceuticals Limited. The company manufactures medicines at its facilities in India, which it then sells domestically and exports to countries in Asia, Africa